Tribun Health

Tribun Health

Paris, France· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $30M

Overview

Tribun Health is a Paris-based leader in the digital pathology and AI diagnostics sector, offering a CE-marked and Health Canada-approved platform centered on its CaloPix® image management system. The company's integrated suite includes tools for macroscopic image capture (MacroCam), secure data storage (CaloPix® Archive), a growing catalog of AI applications for image analysis, and a telepathology module (TeleSlide® Patho). By enabling a fully digital diagnostic workflow and providing tools for pharmaceutical cohort building, Tribun Health is positioned at the intersection of clinical diagnostics and drug development, addressing critical needs in an era of increasing cancer cases and specialized care.

Oncology

Technology Platform

Integrated digital pathology software platform centered on the CaloPix® image management system. The web-native, cloud-agnostic platform includes modules for macroscopic image capture (MacroCam), secure data storage/archive, a growing catalog of AI applications for image analysis, and telepathology (TeleSlide® Patho). It is designed for end-to-end digitization of pathology workflows.

Funding History

2
Total raised:$30M
Series B$20M
Series A$10M

Opportunities

The global shift to digital pathology and AI-augmented diagnostics, driven by a pathologist shortage and the complexity of personalized cancer care, presents a massive growth opportunity.
Additionally, the company's platform enables a valuable data and technology service for pharmaceutical companies in drug development and biomarker discovery, creating a high-value secondary market.

Risk Factors

Key risks include the pace and cost of laboratory adoption of digital workflows, navigating complex and varying medical device regulations across global markets, and intense competition from both large medtech conglomerates and agile AI startups.
Clinical and operational validation of AI tools also remains a significant hurdle.

Competitive Landscape

Tribun Health competes in the digital pathology software and AI market against large, diversified players like Philips, Roche (Ventana), and Leica Biosystems, as well as specialized software companies like Proscia, Paige, and Indica Labs. Its differentiation lies in its agnostic, integrated platform approach, regulatory approvals, and dual focus on clinical and pharma customers.